Skip to main content
Premium Trial:

Request an Annual Quote

Patients Know Best Taps Tute to Provide Genome Analysis

NEW YORK (GenomeWeb) – Provo, Utah-based Tute Genomics said today that Patients Know Best — a developer of an online medical records system — has selected its cloud-based software for genome analysis and interpretation.

According to Tute, the arrangement will make it possible for the UK-based firm to incorporate patients' genetic profiles into their healthcare records, allowing physicians to use this information to customize treatments.

Financial and other terms of the agreement were not disclosed.

Last month, Tute said that it had been selected to provide next-generation sequencing analytics for a molecular diagnostic test being developed by Lineagen for developmental delay, autism spectrum disorders, and other disorders of childhood development.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.